SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001437749-20-018617
Filing Date
2020-08-24
Accepted
2020-08-24 17:04:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A fujp20200824_sc13da.htm SC 13D/A 45374
  Complete submission text file 0001437749-20-018617.txt   46654
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Subject) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83670 | Film No.: 201128577
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEVEL 1, BLDG 1, GREENWOOD BUSINESS PARK 301 BURWOOD HWY BURWOOD C3 3125
Business Address
Fu Jian Ping (Filed by) CIK: 0001668658 (see all company filings)

Type: SC 13D/A